Green Eric Mark's Form 4/A amendment
AmendedWest Pharmaceutical Services IncWST · filed Aug 8, 2024
- Accession no.
- 0001127602-24-021890
- Filed
- Aug 8, 2024
- Trade date
- May 7, 2024
- Filing delay
- 93 days
- Rule 10b5-1 plan
- Checked
- Original filed
- May 9, 2024
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $24.2M. It was filed 93 days after the trade.
This amendment replaces 0001127602-24-014765 (filed May 9, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Green Eric MarkCIK 0001336007 | Director, Officer (President, CEO and Board Chair) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | Common Stock | MOption exerciseAcquired | +9,316 | $57.38 | +$534,552.08 | 162,224.12 | Direct | |
| May 7, 2024 | Common Stock | MOption exerciseAcquired | +15,684 | $57.38 | +$899,947.92 | 177,908.12 | Direct | |
| May 7, 2024 | Common Stock | MOption exerciseAcquired | +41,000 | $59.64 | +$2,445,240 | 218,908.12 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −9,316 | $366.64F2 | −$3,415,618.24 | 209,952.12 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −15,684 | $366.66F2 | −$5,750,695.44 | 193,908.12 | Direct | |
| May 7, 2024 | Common Stock | SSaleDisposed | −41,000 | $366.65F2 | −$15,032,650 | 152,908.12 | Direct | |
| May 7, 2024 | Common Stock | MOption exerciseAcquired | +9,000 | $59.64 | +$536,760 | 161,908.12 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | Common Stock | MOption exerciseDisposed | −9,316 | $0.00 | $0 | 0 | Direct | |
| May 7, 2024 | Common Stock | MOption exerciseDisposed | −15,684 | $0.00 | $0 | 0 | Direct | |
| May 7, 2024 | Common Stock | MOption exerciseDisposed | −41,000 | $0.00 | $0 | 45,732 | Direct | |
| May 7, 2024 | Common Stock | MOption exerciseDisposed | −9,000 | $0.00 | $0 | 36,732 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in either 2025 or 2026, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 11/17/2023.
- F2
The price reported in Column 4 is a weighted average price.
Referenced by the price of 3 transactions in Table I.
Remarks
The only change to this form filed on 5/9/2024 is that the Rule 10b5-1(c) box is now checked.